The cell therapy industry is enjoying a period of unprecedented growth. The number of cell-based treatments transitioning from development to commercial manufacturing is forecast to continue growing dramatically over the next decade. This predicted growth rate can only be maintained by a parallel increase in the availability of therapeutic starting materials.
HemaCare scientists have just published a white paper on a new raw material sourcing paradigm that they hope will transform the industry.
The publication centers on dedicated donors; recallable donors who are reserved to specific research programs. The basic premise is that clients will be able to reserve self-identified recallable donors who possess physiological or demographic traits deemed beneficial to a particular research program.
Isolated immune cell populations support a wide variety of research and cell therapy applications. Because purification and preliminary characterization of immune cell subsets can be time-consuming and costly, many researchers prefer to purchase isolated immune cells rather than raw materials.
You wanted cell isolation – we delivered!
In 2021, the word isolation tends to have garnered a negative connotation. However, when a cell biologist thinks of isolation, specifically cell isolation, they think of it as a wonderful thing.
After all, isolated cells are a sought-after starting material that allows scientists to dive deeper into their research and accelerate their studies. At HemaCare, we heard your requests and can now deliver isolated immune cells from full leukopak collections to your doorstep!
New webinar highlights the benefits of “dedicated donor pools” - the latest offering from HemaCare to accelerate successful cell therapy research and commercialization
HemaCare, through Charles River Labs, recently hosted an educational webinar focused on their latest cell and gene therapy-related service.
HemaCare will now be working with clients to establish “dedicated donor” pools. The purpose of this new program is to establish and maintain a pool of reliable, recallable donors with client-determined physiological and/or demographic characteristics that match specific client research projects and programs.